skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Pharmacological treatment of chronic obstructive pulmonary disease

(2479) Views  (566) Full article downloads

Authors: Paolo Montuschi

Published Date February 2006 Volume 2006:1(4) Pages 409 - 423
DOI: http://dx.doi.org/10.2147/COPD.S

Paolo Montuschi

Department of Pharmacology, Faculty of Medicine, Catholic University of the Sacred Heart, Rome, Italy

Abstract: None of the drugs currently available for chronic obstructive pulmonary disease (COPD) are able to reduce the progressive decline in lung function which is the hallmark of this disease. Smoking cessation is the only intervention that has proved effective. The current pharmacological treatment of COPD is symptomatic and is mainly based on bronchodilators, such as selective β2-adrenergic agonists (short- and long-acting), anticholinergics, theophylline, or a combination of these drugs. Glucocorticoids are not generally recommended for patients with stable mild to moderate COPD due to their lack of efficacy, side effects, and high costs. However, glucocorticoids are recommended for severe COPD and frequent exacerbations of COPD. New pharmacological strategies for COPD need to be developed because the current treatment is inadequate.

Keywords: Chronic obstructive pulmonary disease, pharmacological treatment, bronchodilators, glucocorticoids, theophylline, antibiotics.








Readers of this article also read:

Pulmonary stem cells and the induction of tissue regeneration in the treatment of emphysema
Influenza: the virus and prophylaxis with inactivated influenza vaccine in “at risk” groups, including COPD patients
Long-term oxygen therapy: Are we prescribing appropriately?
The influence of the media on COPD patients’ knowledge regarding cardiopulmonary resuscitation
Knowledge and attitudes of family physicians coming to COPD continuing medical education
Exacerbation rate, health status and mortality in COPD – a review of potential interventions
Information technology in pharmacovigilance: Benefits, challenges, and future directions from industry perspectives
Retinal nerve fiber layer thickness in recovered and persistent amblyopia
Evaluation of analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0.5% following LASEK or Epi-LASIK
Primary care for diabetes mellitus: perspective from older patients
  • Journal Indexing

    See where all the Dove Press journals are indexed

  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio